This barrier is unrelated to the end of the transition period, following the United Kingdom's departure from the EU.

Public ID: PID-6947R9

Current tendering process for public procurement of pharmaceuticals in Indonesia affecting UK exports

in Indonesia

Trade barrier summary

In Indonesia, the current bidding system for public contracts makes it difficult to add medicines to the market. It has become increasingly difficult to list new medicines in Indonesia’s National Formulary, in which listing decisions appear to be primarily based on price and the overall BPJS budget. This is a significant barrier to trade since it is not consistent with international guidelines that state that listing decisions should reflect multiple sources of evidence, which include scientific data demonstrating drug safety and efficacy.

Sectors affected

  • Pharmaceuticals and biotechnology



Date reported

14 September 2020

Last updated

17 December 2020

Public ID


Back to search results

If a trade barrier is affecting your exports or investment from the UK, please let us know on report a trade barrier .

If you export goods you can check duties and customs procedures for your chosen market.